These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis. Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898 [TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin causes coronary vasodilation in humans: effects of inhibition of nitric oxide synthesis. Ueda K; Teragawa H; Kimura M; Matsuda K; Higashi Y; Yamagata T; Oshima T; Yoshizumi M; Chayama K J Cardiovasc Pharmacol; 2005 Oct; 46(4):534-9. PubMed ID: 16160609 [TBL] [Abstract][Full Text] [Related]
5. Acetylcholine acutely modifies nitric oxide synthase function in the human coronary circulation. Miner SE; Al-Hesayen A; Nield LE; Gori T; Parker JD Exp Physiol; 2010 Dec; 95(12):1167-76. PubMed ID: 20817701 [TBL] [Abstract][Full Text] [Related]
6. Prolonged sinus node recovery time in humans after the intracoronary administration of a nitric oxide synthase inhibitor. Exner DV; Goodhart DM; Anderson TJ; Duff HJ J Cardiovasc Pharmacol; 1999 Jul; 34(1):1-6. PubMed ID: 10413059 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandins do not contribute to the nitric oxide-mediated compensatory vasodilation in hypoperfused exercising muscle. Casey DP; Joyner MJ Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H261-8. PubMed ID: 21536852 [TBL] [Abstract][Full Text] [Related]
8. A dose-response study of nitric oxide synthase inhibition in different vascular beds in man. Hjorth Lassen L; Klingenberg Iversen H; Olesen J Eur J Clin Pharmacol; 2003 Oct; 59(7):499-505. PubMed ID: 13680036 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of PET-measured longitudinal flow gradient for the identification of coronary artery disease. Valenta I; Quercioli A; Schindler TH JACC Cardiovasc Imaging; 2014 Apr; 7(4):387-96. PubMed ID: 24631507 [TBL] [Abstract][Full Text] [Related]
10. Repeatability of Fractional Flow Reserve Despite Variations in Systemic and Coronary Hemodynamics. Johnson NP; Johnson DT; Kirkeeide RL; Berry C; De Bruyne B; Fearon WF; Oldroyd KG; Pijls NHJ; Gould KL JACC Cardiovasc Interv; 2015 Jul; 8(8):1018-1027. PubMed ID: 26205441 [TBL] [Abstract][Full Text] [Related]
11. The contribution of nitric oxide to exercise hyperemia in the human forearm. Gordon MB; Jain R; Beckman JA; Creager MA Vasc Med; 2002 Aug; 7(3):163-8. PubMed ID: 12553738 [TBL] [Abstract][Full Text] [Related]
12. Heterogenous vasodilator pathways underlie flow-mediated dilation in men and women. Parker BA; Tschakovsky ME; Augeri AL; Polk DM; Thompson PD; Kiernan FJ Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1118-26. PubMed ID: 21642502 [TBL] [Abstract][Full Text] [Related]
13. Effects of nitric oxide synthase inhibition and endothelin ETA receptor blockade on haemodynamics in hypertensive rats. Granstam SO; Lind L; Granstam E; Fellström B Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):693-701. PubMed ID: 9750958 [TBL] [Abstract][Full Text] [Related]
14. Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve. Rudzinski W; Waller AH; Rusovici A; Dehnee A; Nasur A; Benz M; Sanchez S; Klapholz M; Kaluski E Catheter Cardiovasc Interv; 2013 Feb; 81(3):540-4. PubMed ID: 22961876 [TBL] [Abstract][Full Text] [Related]
15. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193 [TBL] [Abstract][Full Text] [Related]
16. Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans. Tagawa T; Mohri M; Tagawa H; Egashira K; Shimokawa H; Kuga T; Hirooka Y; Takeshita A J Cardiovasc Pharmacol; 1997 Apr; 29(4):546-53. PubMed ID: 9156366 [TBL] [Abstract][Full Text] [Related]
17. Intracarotid infusion of the nitric oxide synthase inhibitor, L-NMMA, modestly decreases cerebral blood flow in human subjects. Joshi S; Young WL; Duong DH; Ostapkovich ND; Aagaard BD; Hashimoto T; Pile-Spellman J Anesthesiology; 2000 Sep; 93(3):699-707. PubMed ID: 10969303 [TBL] [Abstract][Full Text] [Related]
18. Optimal Adenosine Stress for Maximum Stress Perfusion, Coronary Flow Reserve, and Pixel Distribution of Coronary Flow Capacity by Kolmogorov-Smirnov Analysis. Kitkungvan D; Lai D; Zhu H; Roby AE; Johnson NP; Steptoe DD; Patel MB; Kirkeeide R; Gould KL Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28213449 [TBL] [Abstract][Full Text] [Related]
19. Contribution of nitric oxide and prostaglandins to reactive hyperemia in human forearm. Engelke KA; Halliwill JR; Proctor DN; Dietz NM; Joyner MJ J Appl Physiol (1985); 1996 Oct; 81(4):1807-14. PubMed ID: 8904603 [TBL] [Abstract][Full Text] [Related]